Table 3 Complications during postoperative and follow-up periods in both groups
Complications | Group A(24 hips) | Group B(20 hips) | Statistic quantity | P-value |
|---|---|---|---|---|
Opportunistic infections(n) | Â | Â | Â | Â |
Oral cytomegalovirus infection | 1 | 0 | Â | Â |
Pneumocystis carinii pneumonia | 1 | 0 | Â | Â |
Deep vein thrombosis(n) | 0 | 0 | Â | Â |
Hip pain on the operated side(n) | 4 | 4 | Â | Â |
THR for increased necrosis(n) | 2 | 3 | - | 1.00 |
Resorption and collapse of implant THR on the operated side again(n) | 1 | 2 | Â | Â |
Contralateral ONFH(n) | 3 | 4 | Â | Â |
Total morbidity (%) | 37.5 | 45 | X2 = 0.25 | 0.42 |